Vestn Dermatol Venerol
June 1989
The authors compare the efficacy and tolerance of rectal (in suppositories) and oral administration of puvalen in 117 patients. The therapy has been highly effective in both the groups; clinical remission has been achieved in 78% of Group 1 patients and in 80% of Group 2 ones. Rectal puvalen has been better tolerated; the incidence rate of side effects has been 4 times lower.
View Article and Find Full Text PDF